Your browser doesn't support javascript.
loading
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.
Pulsipher, Michael A; Langholz, Bryan; Wall, Donna A; Schultz, Kirk R; Bunin, Nancy; Carroll, William L; Raetz, Elizabeth; Gardner, Sharon; Gastier-Foster, Julie M; Howrie, Denise; Goyal, Rakesh K; Douglas, James G; Borowitz, Michael; Barnes, Yvonne; Teachey, David T; Taylor, Candace; Grupp, Stephan A.
Affiliation
  • Pulsipher MA; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute/University of Utah School of Medicine, Primary Children's Hospital, Salt Lake City, UT;
Blood ; 123(13): 2017-25, 2014 Mar 27.
Article in En | MEDLINE | ID: mdl-24497539

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Tacrolimus / Sirolimus / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Graft vs Host Disease / Immunosuppressive Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Blood Year: 2014 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Tacrolimus / Sirolimus / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Graft vs Host Disease / Immunosuppressive Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Blood Year: 2014 Document type: Article Country of publication: United States